BioSpace News Archive

Retrophin, Inc. (Nasdaq: RTRX) today announced that on September 10, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase an aggregate of 38,250 shares of its common stock to four new employees and granted inducement restricted stock units, or RSUs, covering an aggregate of 7,475 shares of its common stock to six new employees.

The Elie Hirschfeld Foundation announces the dedication of $100,000 to the Weizmann Institute of Science in Israel.

Outset Medical, Inc. announced the pricing of its upsized initial public offering of 8,951,111 shares of its common stock at a public offering price of $27.00 per share, for total gross proceeds of approximately $241.7 million, before deducting underwriting discounts and commissions and offering expenses.

GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced that the company will participate in the Cantor Virtual Global Healthcare Conference on September 16 at 3:20 p.m. (ET).

Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical stage biotechnology company developing a next generation anti-CD40 Ligand (CD40L) antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases

TOMI™ Environmental Solutions, Inc. (“TOMI”) (OTCQB:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology® (“BIT™”) platform through its SteraMist® products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (“iHP™”),

Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE:ZRO) is pleased to announce - A strategic licensing partnership with Kleen Bee Labs was finalized today.

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today that its Board of Directors has appointed Lee Rauch,

HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has hired Trent MacDonald to join the Company in the role of Chief Financial Officer, with a start date expected in the coming months.

Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, today announced its fiscal results for the quarter and year ended March 31, 2020 and provided an update on recent corporate developments.